“…Although several of the radioimmunoassays are sufficiently sensitive for therapeutic drug monitoring (4,6,7), all of these methods suffer to some degree from lack of specificity because of one or more of the following reasons: (1) cross-reactivity with known metabolites of glyburide (3-5); (2) nonspecific binding to plasma proteins (4, 6); (3) crossreactivity with other sulfonylureas (6,7). The GLC method that was developed for the analysis of glyburide in human plasma requires reaction of the drug with 2,4-dinitrofluorobenzene to form a volatile, thermally stable derivative that is suitable for electron-capture detection (8). This methodology provides high sensitivity and the known metabolites 1 Senior Independent Project Participant, Department of Chemistry, Kalamazoo College, Kalamazoo, MI 49007.…”